VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Palvella Therapeutics, Inc. (PVLA) Total Return Calculator with Dividends Reinvested

Palvella Therapeutics, Inc.

Popular:

The total return for Palvella Therapeutics, Inc. (PVLA) stock is +467.68% over the past 12 months. So far it's up 29.81% this year. The 5-year total return is +665.71%, meaning $10,000 invested in PVLA stock 5 years ago would be worth $76,571 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in PVLA 1 year ago, it would be worth $56,768 today — you'd have gained $46,768.

With Dividends Reinvested$56,768+467.68%

Price Only (No DRIP)$56,768+467.68%

Period2025-05-06 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in PVLA

1Y$56,768+$46,768 (+467.7%)467.7% CAGR

3Y$76,571+$66,571 (+665.7%)97.1% CAGR

5Y$76,571+$66,571 (+665.7%)50.2% CAGR

10Y$76,571+$66,571 (+665.7%)22.6% CAGR

15Y$76,571+$66,571 (+665.7%)14.5% CAGR

20Y$76,570+$66,570 (+665.7%)10.7% CAGR

30Y$76,570+$66,570 (+665.7%)7.0% CAGR

Palvella Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading PVLA total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+29.81%	—	+29.81%	—	$12,981
1Y	+467.68%	467.68%	+467.68%	—	$56,768
3Y	+665.71%	97.10%	+665.71%	—	$76,571
5Y	+665.71%	50.25%	+665.71%	—	$76,571
10Y	+665.71%	22.58%	+665.71%	—	$76,571
15Y	+665.71%	14.53%	+665.71%	—	$76,571
20Y	+665.70%	10.71%	+665.70%	—	$76,570
30Y	+665.70%	7.02%	+665.70%	—	$76,570

Risk & Highlights

Best Year+772.25%2025

Worst Year-29.41%2024

Max Drawdown-29.93%2025-12-22 → 2026-02-05 · Recovered 2026-02-24

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+34.64%	+34.64%	—	+0.41%	+34.2pp
2025	+772.25%	+772.25%	—	+16.64%	+755.6pp
2024	-29.41%	-29.41%	—	+24.00%	-53.4pp

PVLA outperformed the S&P 500 by 436.36pp over the past year (+467.68% vs +31.32%).

Loading summary...

PVLA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
PVLAPalvella Therapeutics, Inc.	$1.5B	+8.6%	+29.8%	+467.7%	—	+665.7%	+665.7%	+665.7%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
ARDXArdelyx, Inc.	$1.7B	+18.9%	+15.4%	+79.7%	—	+69.5%	+327.7%	+290.1%
RCKTRocket Pharmaceuticals, Inc.	$418M	+11.6%	+11.6%	-38.8%	—	-81.9%	-91.1%	-90.7%
RAREUltragenyx Pharmaceutical Inc.	$2.5B	+13.4%	+9.9%	-26.0%	—	-44.9%	-77.6%	-58.9%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.3%	+1.5%	+134.1%	—	+19.0%	+50.9%	+125.0%
KRYSKrystal Biotech, Inc.	$8.5B	+10.3%	+17.0%	+107.1%	—	+229.6%	+310.3%	+2615.2%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
EDITEditas Medicine, Inc.	$311M	+16.7%	+54.9%	+138.7%	—	-67.0%	-90.8%	-89.5%

Compare:PVLA vs NKTR PVLA vs PRAX PVLA vs IMVT PVLA vs NKTR vs PRAX

About PVLA Dividend Returns

Palvella Therapeutics, Inc. (PVLA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of PVLA over the past year?

Palvella Therapeutics, Inc. (PVLA) delivered a return of 467.68% over the past year. Since PVLA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in PVLA be worth today?

A $10,000 investment in Palvella Therapeutics, Inc. one year ago would be worth $56,768 today, representing a gain of $46,768.

Q3Does PVLA pay dividends?

Palvella Therapeutics, Inc. (PVLA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PVLA, the total return equals the price-only return.

Q4Did PVLA beat the S&P 500?

Yes, Palvella Therapeutics, Inc. (PVLA) outperformed the S&P 500 by 436.36 percentage points over the past year. PVLA delivered a total return of 467.68%, compared to the S&P 500's 31.32%. This 436.36pp alpha means investors in PVLA earned more than a passive S&P 500 index fund.

Q5What is PVLA's worst drawdown?

Palvella Therapeutics, Inc. (PVLA) experienced a maximum drawdown of -29.93% over the past year, declining from its peak on 2025-12-22 to its trough on 2026-02-05. The stock recovered to its prior peak by 2026-02-24. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is PVLA's long-term total return over 10, 20, or 30 years?

Here are Palvella Therapeutics, Inc. (PVLA)'s long-term returns with dividends reinvested. Over 10 years, the total return is 665.7% (22.6% CAGR) — $10,000 would have grown to $76,571. Over 20 years: 665.7% total return (10.7% CAGR) — $10,000 → $76,570. Over 30 years: 665.7% total return (7.0% CAGR) — $10,000 → $76,570. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was PVLA's best and worst year?

Palvella Therapeutics, Inc.'s best calendar year was 2025 with a total return of 772.3%. Its worst year was 2024 with a total return of -29.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 801.7 percentage points.